Low molecular weight heparin prophylaxis in day case surgery

Ir J Med Sci. 2006 Oct-Dec;175(4):26-9. doi: 10.1007/BF03167963.

Abstract

Background: The role of Low molecular weight heparins (LMWH) in day case/short-stay surgery is unknown.

Aim: To characterise the current national use of LMWH prophylaxis in specific day and short stay surgeries.

Methods: A standardised anonymous postal questionnaire was sent to all consultant general surgeons in Ireland. The operations selected were herniorraphy, anorectal, varicose vein and laparoscopic cholecystectomy.

Results: Questionnaires were sent to 82 surgeons in 2003. There was a response rate of 68.3% (56). Fifty-four per cent of respondents said there was a protocol in place for administration of LMWH in day case surgery. Of these 41% were not confident that their protocols were being adhered. Fifty-nine per cent of all respondents said they stratified patients according to individual risk. Thirteen per cent reported occurrence of VTE post day case surgery

Conclusion: This study demonstrates a heterogeneous pattern of administration of LMWH. In the absence of published validated protocols, the authors suggest a consensus day case protocol.

MeSH terms

  • Ambulatory Surgical Procedures*
  • Anticoagulants / therapeutic use*
  • General Surgery
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Ireland
  • Surveys and Questionnaires
  • Thromboembolism / prevention & control*

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight